A detailed history of Castleark Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Castleark Management LLC holds 692,966 shares of ADMA stock, worth $12.1 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
692,966
Previous 838,086 17.32%
Holding current value
$12.1 Million
Previous $9.37 Million 47.85%
% of portfolio
0.58%
Previous 0.39%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.21 - $20.03 $1.63 Million - $2.91 Million
-145,120 Reduced 17.32%
692,966 $13.9 Million
Q2 2024

Aug 13, 2024

BUY
$5.98 - $11.18 $119,456 - $223,331
19,976 Added 2.44%
838,086 $9.37 Million
Q1 2024

May 15, 2024

BUY
$4.4 - $6.74 $3.6 Million - $5.51 Million
818,110 New
818,110 $5.4 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.42B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.